[Treatment of dystrophy, dysplasia and initial stages of vulvar carcinoma in virus infections]

Lik Sprava. 2002:(1):80-4.
[Article in Ukrainian]

Abstract

Overall sixty-seven patients with distrophy, dysplasia and valvular carcinoma presenting with human papilloma virus- and herpes simplex-2 virus infections underwent a complex treatment intended for background, precancerous affections of the vulva and for valvular carcinoma, involving the use of antiviral drug preparations laferon, zovirax, lovir (both on the systemic and local basis), and an immunomodulator (decaris). Efficacy of the above treatment option has been shown to be 98.5%.

Publication types

  • English Abstract

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Female
  • Herpes Genitalis / drug therapy
  • Herpes Genitalis / virology
  • Herpesvirus 2, Human
  • Humans
  • Levamisole / therapeutic use*
  • Middle Aged
  • Papillomaviridae
  • Papillomavirus Infections / drug therapy
  • Papillomavirus Infections / virology
  • Precancerous Conditions / drug therapy*
  • Tumor Virus Infections / drug therapy
  • Tumor Virus Infections / virology
  • Vulva / pathology
  • Vulvar Diseases / drug therapy
  • Vulvar Diseases / virology
  • Vulvar Neoplasms / drug therapy*
  • Vulvar Neoplasms / virology

Substances

  • Adjuvants, Immunologic
  • Antiviral Agents
  • Levamisole